250 related articles for article (PubMed ID: 18452170)
1. Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis.
Evans S; Metcalfe C; Ibrahim F; Persad R; Ben-Shlomo Y
Int J Cancer; 2008 Jul; 123(2):430-435. PubMed ID: 18452170
[TBL] [Abstract][Full Text] [Related]
2. Association of African-American ethnic background with survival in men with metastatic prostate cancer.
Thompson I; Tangen C; Tolcher A; Crawford E; Eisenberger M; Moinpour C
J Natl Cancer Inst; 2001 Feb; 93(3):219-25. PubMed ID: 11158191
[TBL] [Abstract][Full Text] [Related]
3. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
[TBL] [Abstract][Full Text] [Related]
4. Racial differences in prostate cancer treatment outcomes: a systematic review.
Peters N; Armstrong K
Cancer Nurs; 2005; 28(2):108-18. PubMed ID: 15815180
[TBL] [Abstract][Full Text] [Related]
5. Differences in socioeconomic status and survival among white and black men with prostate cancer.
Robbins AS; Whittemore AS; Thom DH
Am J Epidemiol; 2000 Feb; 151(4):409-16. PubMed ID: 10695600
[TBL] [Abstract][Full Text] [Related]
6. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort.
Du XL; Fang S; Coker AL; Sanderson M; Aragaki C; Cormier JN; Xing Y; Gor BJ; Chan W
Cancer; 2006 Mar; 106(6):1276-85. PubMed ID: 16475208
[TBL] [Abstract][Full Text] [Related]
7. Do African American men have lower survival from prostate cancer compared with White men? A meta-analysis.
Sridhar G; Masho SW; Adera T; Ramakrishnan V; Roberts JD
Am J Mens Health; 2010 Sep; 4(3):189-206. PubMed ID: 20483872
[TBL] [Abstract][Full Text] [Related]
8. Race, prostate cancer survival, and membership in a large health maintenance organization.
Robbins AS; Whittemore AS; Van Den Eeden SK
J Natl Cancer Inst; 1998 Jul; 90(13):986-90. PubMed ID: 9665146
[TBL] [Abstract][Full Text] [Related]
9. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.
Shavers VL; Brown ML; Potosky AL; Klabunde CN; Davis WW; Moul JW; Fahey A
J Gen Intern Med; 2004 Feb; 19(2):146-55. PubMed ID: 15009794
[TBL] [Abstract][Full Text] [Related]
10. The Relationship of Baseline Prostate Specific Antigen and Risk of Future Prostate Cancer and Its Variance by Race.
Verges DP; Dani H; Sterling WA; Weedon J; Atallah W; Mehta K; Schreiber D; Weiss JP; Karanikolas NT
J Natl Med Assoc; 2017 Spring; 109(1):49-54. PubMed ID: 28259216
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease.
Powell IJ; Banerjee M; Novallo M; Sakr W; Grignon D; Wood DP; Pontes JE
Urology; 2000 Feb; 55(2):246-51. PubMed ID: 10688088
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen as predictor of prostate cancer in black men and white men.
Whittemore AS; Lele C; Friedman GD; Stamey T; Vogelman JH; Orentreich N
J Natl Cancer Inst; 1995 Mar; 87(5):354-60. PubMed ID: 7531773
[TBL] [Abstract][Full Text] [Related]
13. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer in black and white Americans.
Reddy S; Shapiro M; Morton R; Brawley OW
Cancer Metastasis Rev; 2003 Mar; 22(1):83-6. PubMed ID: 12716039
[TBL] [Abstract][Full Text] [Related]
15. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.
Underwood W; Jackson J; Wei JT; Dunn R; Baker E; Demonner S; Wood DP
Cancer; 2005 Feb; 103(3):538-45. PubMed ID: 15612083
[TBL] [Abstract][Full Text] [Related]
16. Re: Association of African-American ethnic background with survival in men with metastatic prostate cancer.
Polednak AP
J Natl Cancer Inst; 2001 Aug; 93(15):1174-5. PubMed ID: 11481391
[No Abstract] [Full Text] [Related]
17. Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation.
Kim IE; Jang TL; Kim S; Modi PK; Singer EA; Elsamra SE; Kim IY
Cancer; 2020 Dec; 126(23):5114-5123. PubMed ID: 32888321
[TBL] [Abstract][Full Text] [Related]
18. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
[TBL] [Abstract][Full Text] [Related]
19. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
20. Determinants of Prostate Specific Antigen Screening among Black Men in the United States in the Contemporary Era.
Sammon JD; Dalela D; Abdollah F; Choueiri TK; Han PK; Hansen M; Nguyen PL; Sood A; Menon M; Trinh QD
J Urol; 2016 Apr; 195(4 Pt 1):913-8. PubMed ID: 26598427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
